| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Eprex 2000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Eprex 4000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin alfa 4000iu/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Oxymetholone 50mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Nandrolone decanoate 100mg/1mL oily injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Deca-Durabolin 100 oily injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 30mg/10mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 30mg injection (pdr for recon) - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 15mg injection (pdr for recon) - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 3mg/mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 15mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 300mg/30mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 15mg/2mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 350mg/35mL injection solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Lederfolin 350mg/35mL injection solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calcium Leucovorin 100mg/10mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calcium Leucovorin 50mg/5mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calcium Leucovorin 15mg/2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Calcium Leucovorin 300mg/30mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Levofolinic acid 50mg/5mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sodiofolin 900mg/18mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sodiofolin 400mg/8mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Sodiofolin 100mg/2mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 900mg/18mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folinic acid 400mg/8mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folic acid 2.5mg/5mL sugar free syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Preconceive 400micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folic acid 400micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Lexpec 2.5mg/5mL sugar free syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folic acid 5mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Folic acid 100micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cyanocobalamin 35micrograms/5mL oral liquid - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cyanocobalamin 50micrograms tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cytamen 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cytacon 35micrograms/5mL oral liquid |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cytacon 50micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cyanocobalamin 1mg/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Neo-Cytamen 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Cobalin-H 1mg/1mL injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Hydroxocobalamin 1mg/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Venofer 100mg/5mL intravenous solution |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Iron hydroxide sucrose complex 100mg/5mL(Fe) intravenous solution - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Iron sorbitol injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Jectofer injection |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Dencyl Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ditemic Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fortespan Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrous gluconate+folic acid+ascorbic acid 250mg/5mg/10mg tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferric ammonium citrate+folic acid 80mg/2.5mg/5mL syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrous sulphate+folic acid 160mg/400micrograms m/r tablet - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrous fumarate+folic acid 304mg/350micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferric ammonium citrate+folic acid 80mg/500micrograms/5mL syrup - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrous fumarate+folic acid 305mg/350mg capsule - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrous fumarate+folic acid 305mg/400micrograms tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Kloref 500mg effervescent tablet |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Kay-Cee-L 7.5% syrup |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Neupogen Singleject 48million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Neupogen Singleject 30million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 48million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 30million units/0.5mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Neupogen 48million units/1.6mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Neupogen 30million units/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 48million units/1.6mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 30million units/1mL prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 48million units/1.6mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Filgrastim 30million units/1mL injection - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 4000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 6000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 60,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 60,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 6000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 4000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 10,000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 5000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 3000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 2000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 1000iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 500iu prefilled syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 10,000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 5000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 3000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 2000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 1000iu prefilled syringe - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 500iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 20,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 10,000iu injection cartridge |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 20,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 10,000iu injection cartridge - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 100,000iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| NeoRecormon 50,000iu injection (pdr for recon)+solvent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fructose powder - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 100,000iu injection (pdr for recon)+solvent - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 50,000iu injection (pdr for recon)+solvent - product |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Recormon 10,000iu injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Recormon S 10,000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Recormon S 5000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 10,000iu injection+diluent |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Epoetin beta 10,000iu injection+diluent+syringe |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Ferrograd-C Filmtab |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Fefol Z Spansule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|
| Polysaccharide iron complex capsule |
CSM recommendation to report adverse reactions |
False |
Report only serious adverse reactions to the Committee on Safety of Medicines |
Additional relationship |
Existential restriction modifier |
|